Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net increase/(decrease) in net assets resulting from operations	$ 41,149	$ 1,392
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(3,335)	(184)
Net change in unrealized (gain) loss on investments	(27,850)	(447)
Net realized (gain) loss on derivatives	150	0
Net change in unrealized (gain) loss on derivatives	6,279	478
Payments to purchase investments	(1,909,572)	(87,578)
Proceeds from sale of investments	1,104,886	11,381
Payments to purchase derivatives	(34,998)	(6,000)
Proceeds from sale of derivatives	(151)	0
Changes in operating assets and liabilities:
(Increase)/decrease in receivable for investments sold	(11,473)	0
(Increase)/decrease in due from Operating Manager	(4,825)	(3,447)
(Increase)/decrease in interest receivable	(9,752)	(560)
(Increase)/decrease in dividends receivable	(9,049)	0
(Increase)/decrease in deferred offering expenses	480	(1,544)
(Increase)/decrease in capital subscriptions receivable	342	0
(Increase)/decrease in prepaid expenses and other assets	(12,517)	(957)
Increase/(decrease) in distributions payable	2,358	0
Increase/(decrease) in Due to Operating Manager	6,506	5,227
Increase/(decrease) in payable for investments purchased	(15)	3,435
Increase/(decrease) in performance fees payable	3,670	28
Increase/(decrease) in management fees payable	942	58
Increase/(decrease) in interest payable	6,214	34
Increase/(decrease) in capital subscriptions received in advance	(450)	0
Increase/(decrease) in organizational expenses payable	0	(564)
Increase/(decrease) in offering expenses payable	0	(677)
Increase/(decrease) in repurchases payable	0	(0)
Increase/(decrease) in other accrued expenses and liabilities	3,535	1,136
Net cash provided by (used in) operating activities	(847,476)	(78,789)
Financing activities
Notes Borrowings	124	1,072
Proceeds from issuance of shares	919,772	90,770
Repurchases of shares	(17,070)	0
Distributions declared	(34,126)	0
Net cash provided by (used in) financing activities	868,700	91,842
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	21,224	13,053
Cash and cash equivalents at beginning of period	58,587	2
Cash and cash equivalents at end of period	79,811	13,055
Supplemental disclosure of cash flow information:
Income taxes paid	824	0
Cash paid for interest	938	0
Series I
Operating activities
Net increase/(decrease) in net assets resulting from operations	8,241	157
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(740)	(29)
Net change in unrealized (gain) loss on investments	(6,775)	(53)
Net realized (gain) loss on derivatives	(45)	0
Net change in unrealized (gain) loss on derivatives	1,803	58
Payments to purchase investments	(313,510)	(14,072)
Proceeds from sale of investments	154,501	1,826
Payments to purchase derivatives	(7,291)	(944)
Proceeds from sale of derivatives	44	0
Changes in operating assets and liabilities:
(Increase)/decrease in receivable for investments sold	(2,498)	0
(Increase)/decrease in due from Operating Manager	(608)	(340)
(Increase)/decrease in interest receivable	(1,277)	(90)
(Increase)/decrease in dividends receivable	(1,971)	0
(Increase)/decrease in deferred offering expenses	308	211
(Increase)/decrease in capital subscriptions receivable	540	0
(Increase)/decrease in prepaid expenses and other assets	(2,497)	(215)
Increase/(decrease) in distributions payable	321	0
Increase/(decrease) in Due to Operating Manager	883	839
Increase/(decrease) in payable for investments purchased	(357)	551
Increase/(decrease) in performance fees payable	882	10
Increase/(decrease) in management fees payable	252	23
Increase/(decrease) in interest payable	639	17
Increase/(decrease) in capital subscriptions received in advance	0	0
Increase/(decrease) in organizational expenses payable	0	(304)
Increase/(decrease) in offering expenses payable	0	(567)
Increase/(decrease) in repurchases payable	0	(0)
Increase/(decrease) in other accrued expenses and liabilities	1,733	190
Net cash provided by (used in) operating activities	(167,422)	(12,732)
Financing activities
Notes Borrowings	27	536
Proceeds from issuance of shares	191,888	14,600
Repurchases of shares	(15,860)	0
Distributions declared	(6,782)	0
Net cash provided by (used in) financing activities	169,273	15,136
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	1,851	2,404
Cash and cash equivalents at beginning of period	16,817	1
Cash and cash equivalents at end of period	18,668	2,405
Supplemental disclosure of cash flow information:
Income taxes paid	824	0
Cash paid for interest	256	0
Series II
Operating activities
Net increase/(decrease) in net assets resulting from operations	32,908	1,235
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss on investments	(2,595)	(155)
Net change in unrealized (gain) loss on investments	(21,075)	(394)
Net realized (gain) loss on derivatives	195	0
Net change in unrealized (gain) loss on derivatives	4,476	420
Payments to purchase investments	(1,596,062)	(73,506)
Proceeds from sale of investments	950,385	9,555
Payments to purchase derivatives	(27,707)	(5,056)
Proceeds from sale of derivatives	(195)	0
Changes in operating assets and liabilities:
(Increase)/decrease in receivable for investments sold	(8,975)	0
(Increase)/decrease in due from Operating Manager	(4,217)	(3,107)
(Increase)/decrease in interest receivable	(8,475)	(470)
(Increase)/decrease in dividends receivable	(7,078)	0
(Increase)/decrease in deferred offering expenses	172	(1,755)
(Increase)/decrease in capital subscriptions receivable	(198)	0
(Increase)/decrease in prepaid expenses and other assets	(10,020)	(742)
Increase/(decrease) in distributions payable	2,037	0
Increase/(decrease) in Due to Operating Manager	5,623	4,388
Increase/(decrease) in payable for investments purchased	342	2,884
Increase/(decrease) in performance fees payable	2,788	18
Increase/(decrease) in management fees payable	690	35
Increase/(decrease) in interest payable	5,575	17
Increase/(decrease) in capital subscriptions received in advance	(450)	0
Increase/(decrease) in organizational expenses payable	0	(260)
Increase/(decrease) in offering expenses payable	0	(110)
Increase/(decrease) in repurchases payable	0	(0)
Increase/(decrease) in other accrued expenses and liabilities	1,802	946
Net cash provided by (used in) operating activities	(680,054)	(66,057)
Financing activities
Notes Borrowings	97	536
Proceeds from issuance of shares	727,884	76,170
Repurchases of shares	(1,210)	0
Distributions declared	(27,344)	0
Net cash provided by (used in) financing activities	699,427	76,706
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	19,373	10,649
Cash and cash equivalents at beginning of period	41,770	1
Cash and cash equivalents at end of period	61,143	10,650
Supplemental disclosure of cash flow information:
Income taxes paid	0	0
Cash paid for interest	$ 682	$ 0